JPM downgrades key homebuilder stock amid challenging supply-demand dynamics

J.P. Morgan adopts a cautious outlook on U.S. homebuilders for 2025, downgrading key stocks amid supply challenges and stagnant housing demand.

Barclays downgrades US homebuilder stocks as risk-reward turns more balanced

Barclays downgraded several homebuilder stocks due to high interest rates, uncertain policies, and an imbalance in risk/reward, while upgrading Owens Corning and Taylor Morrison for their valuations.

Stocks to watch as White House race enters final stretch

The article discusses expectations around stock markets ahead of the U.S. presidential election, highlighting potential impacts from either Trump or Harris on various sectors and stocks.

Earnings call: D.R. Horton reports mixed Q4 results, eyes spring season

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.36%

U.S. stocks ended mixed with gains in technology, healthcare, and consumer services, while declines occurred in utilities. Notable performance shifts included significant price changes among top companies.

Ford, PayPal and DR Horton fall premarket; Pfizer rises

US stock futures are steady as investors await corporate earnings, with significant premarket movers like Ford and Pfizer reacting to earnings results.

D.R. Horton sees downbeat 2025 sales on buyer uncertainty, shares drop

D.R. Horton forecasts lower 2025 revenue and home deliveries amid volatile mortgage rates, missing profit estimates, leading to a significant drop in shares.

D.R. Horton stock falls on disappointing Q4 results and 2025 guidance

D.R. Horton shares fell over 5% after missing Q4 earnings and issuing weak 2025 guidance; focus remains on affordability and homebuyer incentives amid market challenges.

Wall Street muted ahead of Alphabet earnings

Wall Street remained stable as investors analyzed corporate earnings and awaited Alphabet's report, amidst rising bond yields and mixed earnings from tech companies.